GGGabriel Webert Gomes

Gabriel Webert Gomes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gabriel Webert Gomes has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Susceptibility of Rhipicephalus microplus to fluralaner: assessment before and after implementation of a strategic control protocol in taurine cattle in a tropical region

    by Haile Dean Figueiredo Chagas, Gabriel Webert Gomes, Rafael Assunção Carvalho, Arthur Matos de Santana, Ana Carolinne Lopes Ascenção, Emanuel Magalhães Souza, Bruno César Ferreira Gonzaga, Lorena Lopes Ferreira, Daniel de Castro Rodrigues, Welber Daniel Zanetti Lopes, et al.

    Background: Fluralaner has been used in the strategic control of the Rhipicephalus microplus tick, an important ectoparasite for cattle farming. However, the effects of its application on the susceptibility profiles of these tick populations after treatment have not yet been investigated. In this study, we evaluated the effect of a strategic control protocol with fluralaner on the phenotypic susceptibility profile of a population of R. microplus before and after its implementation. Methods: Thirty naturally infested cattle were divided into two experimental groups: T01 (control group): cattle treated with a topical (spray) formulation containing a synthetic pyrethroid and two organophosphates; T02 (strategic control): cattle treated with a formulation (pour-on) containing only fluralaner. For group T01, animals were treated when the average tick count was ≥30 to allow determination of the infestation challenge on the farm, while animals in group T02 were treated when 30% of the animals had adult ticks < 4 mm. Tick counts on animals were performed every 7 days for 266 days. Larvae monitoring in the pasture was performed every 30 days using a dragging flannel for 240 days. Larval immersion tests (LIT) and adult immersion tests (AIT) were used to assess the phenotypic susceptibility profile of ticks before and after the implementation of the strategic control protocol over a tick season in a tropical region. Results: The animals in the group treated with fluralaner (T02) had lower mean tick counts ( p ≤ 0.05) than those observed in the control group (T01) in 35 of the 38 evaluations during the 266 days of the study. In the pasture, the number of larvae in T02 was lower ( p < 0.05) in seven of the eight evaluations. There was no increase in LC50 values for larvae and engorged females after using the strategic control protocol with fluralaner for 9 months. Conclusions: The use of the strategic control protocol with fluralaner resulted in a significant reduction in tick numbers on cattle and in pastures, and after 1 year of use, the population remained susceptible to this compound. No upward trend in LC50 values was observed after 9 months of fluralaner use.

  • Open Access

    Assessing the susceptibility of 200 Rhipicephalus microplus populations to fluralaner using larval immersion test: A nationwide analysis from Brazil

    by Haile Dean Figueiredo Chagas, Arthur Matos de Santana, Gabriel Webert Gomes, Ana Carolinne Lopes Ascenção, Emanuel Magalhães Souza, Laura Cristina Ferreira Faria, Mayara Macedo Barrozo, Ana Lucia Coutinho Teixeira, Daniel de Castro Rodrigues, Fernando de Almeida Borges, et al.

    Background: In 2022, a tick control product, against Rhipicephalus microplus , containing fluralaner as the active ingredient was initially launched in the Brazilian market, followed by other markets across Latin America. Once a new molecule is introduced for the control of a parasitic organism, it becomes essential to develop methods for assessing the susceptibility of target parasitic populations. In this context, discriminating dose (DD) tests represent a valuable tool. Methods: This study evaluated the susceptibility profile of 200 R. microplus populations originating from 21 federal units (20 states and a federal district) across all five regions of Brazil, using a larval immersion test (LIT) with two discriminating doses (DD) of 1.55 and 3.16 µg/mL. Populations showing mortality rates above 95% were classified as susceptible. A field trial was also conducted with one population (São José do Rio Pardo [SJRP]), which had a known history of exposure to fluralaner, to compare laboratory and field test outcomes. Results: The DD at a concentration of 1.55 µg/mL resulted in 100% mortality in 160 populations (80%), whereas the DD at a concentration of 3.16 µg/mL showed more consistent results, with 100% mortality in 182 populations (91%). In the field trial population, SJRP, fluralaner achieved 100% therapeutic efficacy (days +7 to +21) and persistent efficacy (days +28 to +42). Conclusions: LIT using DDs can provide indicative data on the susceptibility of R. microplus to fluralaner. The discriminating dose at a concentration of 3.16 µg/mL was shown to be the most appropriate for monitoring the susceptibility of R. microplus populations to fluralaner. Laboratory and field data support the classification of the SJRP population as susceptible, demonstrating consistency between the two sets of results. These results can serve as a basis for continuous spatial and temporal monitoring of the susceptibility of R. microplus populations to fluralaner. Continued research, integrating laboratory and field results, is essential to increase the reliability of laboratory-based testing.


  • Open Access

    Acaricidal efficacy of fluralaner against Rhipicephalus microplus ticks under laboratory and field conditions in Brazil

    by Daniel de Castro Rodrigues, Gabriel Webert Gomes, Francisca Leticia Vale, Ana Lúcia Coutinho Teixeira, Isabela Santos Silva, Haile Dean Figueiredo Chagas, Tom Strydom, Siddartha Torres, Rafael Paranhos de Mendonça, Fernando de Almeida Borges, et al.

    Background: The first isoxazoline-based acaricide (fluralaner) for the control of Rhipicephalus microplus was introduced onto the market in 2022, initially in Brazil, followed by other Latin American countries. Therefore, it is important to establish laboratory methods to monitor the susceptibility of populations of R. microplus to this molecule and to determine the relationship between the results of laboratory tests and those from field trials. Methods: A larval immersion test (LIT) was performed on 18 populations of R. microplus. The lethal concentration 50 (concentration causing 50% mortality [LC50]) values were calculated to determine the resistance ratios (RRs) of the populations. The lethal concentration 99 (concentration causing 99% mortality [LC99]) values were calculated to determine the discriminating doses (DDs = 2 × LC99). The DDs were applied in tests with the POA (susceptible) and GYN (resistant) strains, as well as in tests with the population that presented the lowest LC50 value (population 14) and with the two populations that presented the highest LC50 value (populations 10 and 16). Finally, we performed field trials with the population that presented the lowest and two highest LC50 values. Results: In the LIT with fluralaner, the LC50 values ranged from 0.144 to 0.481 µg/mL for the 18 R. microplus populations. The mortality rate was 100% in the tests of the DDs in the five populations tested. In the field trials, the efficacy of fluralaner was similar for the three populations of R. microplus tested (populations 14, 10 and 16), with therapeutic efficacy (until day 21) of 100% and persistent efficacy (between days 28 and 42) > 95%. Conclusion: We observed natural variability in the susceptibility of larvae from the different populations of R. microplus that had never been treated with this compound. Despite the observed variability in the in vitro results (LC50), a comparable efficacy of > 90% lasting until day 42 was observed in the field trials. Also, based on the results of the laboratory testing (LC50 and DD) and field trials, we can conclude that there was no resistance to fluralaner in the 18 studied tick populations. Graphical